On my recent visit to Colossal Biosciences’ new Dallas headquarters, still under construction ahead of its October opening, I asked for the latest update on one of the company’s most ambitious projects: the return of the woolly mammoth.
On my recent visit to Colossal Biosciences’ new Dallas headquarters, still under construction ahead of its October opening, I asked for the latest update on one of the company’s most ambitious projects: the return of the woolly mammoth.